Atlas Trials

CC100: Safety and Tolerability of Single Doses

Clinical trial NCT02050334 · COMPLETED

Trial details

NCT number
NCT02050334
Sponsor
Chemigen, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2013-11-01
Primary completion
2014-07-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.